CD8A and neoplasm: Given the increased immunogenicity within the TME in T1-44 treated tumours, suggested by the infiltrating CD8 T lymphocytes (Fig. 1E), we tested whether the lncRNA-derived MHC class I bound peptides could in part be responsible and therefore examined their immunogenicity in mice.